GSE118319
Genome-wide RNA-seq from GSK-J4-treated lung adenocarcinoma cell lines
Purpose: The goals of our study were to identify downstream pathway regulated by GSK-J4 in lung adenocarcinoma Methods: RNAs isolated from GSK-J4-treated or untreated lung adenocarcinoma (HCC827, H23 and A549) were analyzed by using an Illumina Nextseq500 Conclusions: Our study represents the first detailed transcriptomic analysis of effects of GSK-J4 in lung adenocarcinoma. Overall design: mRNAs prepared from GSK-J4-treated or untreated lung adenocarcinoma cell lines were analyzed in duplicaters by Illumina Nextseq500.